Vertex Pharmaceuticals VRTX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vertex Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vertex Pharmaceuticals's total current assets?
- Vertex Pharmaceuticals (VRTX) reported total current assets of $11.73B in Q1 2026.
- How has Vertex Pharmaceuticals's total current assets changed year-over-year?
- Vertex Pharmaceuticals's total current assets increased by 17.2% year-over-year, from $10.01B to $11.73B.
- What is the long-term trend for Vertex Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's total current assets has grown at a 6.6% compound annual growth rate (CAGR), from $8.13B to $11.2B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.